US Stock MarketDetailed Quotes

IBO Impact BioMedical

Watchlist
  • 2.750
  • +0.020+0.73%
Close Nov 27 16:00 ET
  • 2.760
  • +0.010+0.36%
Post 20:01 ET
31.64MMarket Cap27.23P/E (TTM)

Impact BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0.00%50K
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
0.00%50K
--0
Cost of revenue
Gross profit
Operating expense
4.55%1.13M
-37.90%626K
-3.99%771K
16.62%4.03M
10.37%1.14M
21.26%1.08M
26.00%1.01M
13.26%803K
0.00%3.45M
-23.16%1.03M
Selling and administrative expenses
65.29%719K
-26.86%335K
28.78%434K
50.62%1.58M
194.61%601K
59.34%435K
59.58%458K
35.34%337K
0.00%1.05M
-54.67%204K
-Selling and marketing expense
2,611.76%461K
80.00%18K
-52.94%8K
----
----
--17K
--10K
--17K
----
----
-General and administrative expense
-38.28%258K
-29.24%317K
33.13%426K
50.62%1.58M
216.18%645K
53.11%418K
56.10%448K
28.51%320K
0.00%1.05M
-54.67%204K
Research and development costs
-77.03%82K
--0
-72.07%50K
-6.44%1.15M
-82.38%92K
8.18%357K
29.13%266K
6.55%179K
0.00%1.23M
-10.15%522K
Depreciation amortization depletion
0.36%281K
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
-Depreciation and amortization
0.36%281K
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
Other operating expenses
650.00%45K
200.00%12K
0.00%7K
170.59%184K
492.86%166K
-14.29%6K
-86.21%4K
-50.00%7K
0.00%68K
-17.65%28K
Operating profit
-4.55%-1.13M
37.90%-626K
3.99%-771K
-18.33%-4.03M
-10.37%-1.14M
-21.26%-1.08M
-34.40%-1.01M
-13.26%-803K
0.00%-3.4M
20.19%-1.03M
Net non-operating interest income expense
-205.05%-302K
-128.32%-258K
-131.63%-227K
1.60%-431K
31.84%-122K
-11.24%-99K
-130.61%-113K
-164.86%-98K
0.00%-438K
47.81%-179K
Non-operating interest income
0.00%3K
0.00%3K
0.00%3K
-45.83%13K
103.75%3K
0.00%3K
-96.67%3K
-96.88%3K
0.00%24K
-35.59%-80K
Non-operating interest expense
199.02%305K
125.00%261K
127.72%230K
-3.90%444K
26.26%125K
10.87%102K
-16.55%116K
-24.06%101K
0.00%462K
-65.14%99K
Other net income (expense)
5.67M
101.29%52K
0
52K
0.00%-4.03M
Gain on sale of security
--5.67M
----
----
----
----
----
----
----
----
----
Special income (charges)
----
----
----
--0
----
----
----
----
0.00%-4.1M
----
-Write off
----
----
----
--0
----
----
----
----
0.00%4.1M
----
Other non- operating income (expenses)
----
----
----
-21.21%52K
--0
----
----
--52K
0.00%66K
----
Income before tax
460.32%4.24M
21.14%-884K
-17.55%-998K
44.05%-4.41M
75.96%-1.26M
-20.35%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.88M
8.70%-5.25M
Income tax
0
0
0
0
0
0
0
0
0.00%-621K
-378.12%-1.88M
Net income
460.32%4.24M
21.14%-884K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
47.36%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
Net income continuous Operations
460.32%4.24M
21.14%-884K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
47.36%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
Minority interest income
60.00%-6K
126.32%5K
81.25%-36K
65.20%-71K
-550.00%-26K
77.61%-15K
71.64%-19K
-149.35%-192K
0.00%-204K
-105.13%-4K
Net income attributable to the parent company
465.49%4.25M
19.33%-889K
-46.42%-962K
38.51%-4.34M
63.27%-1.24M
46.43%-1.16M
-50.55%-1.1M
1.79%-657K
0.00%-7.05M
38.08%-3.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
465.49%4.25M
19.33%-889K
-46.42%-962K
38.51%-4.34M
63.27%-1.24M
46.43%-1.16M
-50.55%-1.1M
1.79%-657K
0.00%-7.05M
38.08%-3.36M
Basic earnings per share
466.10%0.37
19.33%-0.0773
-46.42%-0.0837
38.51%-0.3771
63.27%-0.1074
46.43%-0.1011
-50.55%-0.0958
1.81%-0.0571
0.00%-0.6133
38.08%-0.2924
Diluted earnings per share
159.37%0.06
19.33%-0.0773
-46.42%-0.0837
38.51%-0.3771
63.27%-0.1074
46.43%-0.1011
-50.55%-0.0958
1.81%-0.0571
0.00%-0.6133
38.08%-0.2924
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000000000.00%50K0
Operating revenue --0--0--0--0--0--0--0--00.00%50K--0
Cost of revenue
Gross profit
Operating expense 4.55%1.13M-37.90%626K-3.99%771K16.62%4.03M10.37%1.14M21.26%1.08M26.00%1.01M13.26%803K0.00%3.45M-23.16%1.03M
Selling and administrative expenses 65.29%719K-26.86%335K28.78%434K50.62%1.58M194.61%601K59.34%435K59.58%458K35.34%337K0.00%1.05M-54.67%204K
-Selling and marketing expense 2,611.76%461K80.00%18K-52.94%8K----------17K--10K--17K--------
-General and administrative expense -38.28%258K-29.24%317K33.13%426K50.62%1.58M216.18%645K53.11%418K56.10%448K28.51%320K0.00%1.05M-54.67%204K
Research and development costs -77.03%82K--0-72.07%50K-6.44%1.15M-82.38%92K8.18%357K29.13%266K6.55%179K0.00%1.23M-10.15%522K
Depreciation amortization depletion 0.36%281K-0.36%279K0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K
-Depreciation and amortization 0.36%281K-0.36%279K0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K
Other operating expenses 650.00%45K200.00%12K0.00%7K170.59%184K492.86%166K-14.29%6K-86.21%4K-50.00%7K0.00%68K-17.65%28K
Operating profit -4.55%-1.13M37.90%-626K3.99%-771K-18.33%-4.03M-10.37%-1.14M-21.26%-1.08M-34.40%-1.01M-13.26%-803K0.00%-3.4M20.19%-1.03M
Net non-operating interest income expense -205.05%-302K-128.32%-258K-131.63%-227K1.60%-431K31.84%-122K-11.24%-99K-130.61%-113K-164.86%-98K0.00%-438K47.81%-179K
Non-operating interest income 0.00%3K0.00%3K0.00%3K-45.83%13K103.75%3K0.00%3K-96.67%3K-96.88%3K0.00%24K-35.59%-80K
Non-operating interest expense 199.02%305K125.00%261K127.72%230K-3.90%444K26.26%125K10.87%102K-16.55%116K-24.06%101K0.00%462K-65.14%99K
Other net income (expense) 5.67M101.29%52K052K0.00%-4.03M
Gain on sale of security --5.67M------------------------------------
Special income (charges) --------------0----------------0.00%-4.1M----
-Write off --------------0----------------0.00%4.1M----
Other non- operating income (expenses) -------------21.21%52K--0----------52K0.00%66K----
Income before tax 460.32%4.24M21.14%-884K-17.55%-998K44.05%-4.41M75.96%-1.26M-20.35%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.88M8.70%-5.25M
Income tax 000000000.00%-621K-378.12%-1.88M
Net income 460.32%4.24M21.14%-884K-17.55%-998K39.26%-4.41M62.54%-1.26M47.36%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M
Net income continuous Operations 460.32%4.24M21.14%-884K-17.55%-998K39.26%-4.41M62.54%-1.26M47.36%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M
Minority interest income 60.00%-6K126.32%5K81.25%-36K65.20%-71K-550.00%-26K77.61%-15K71.64%-19K-149.35%-192K0.00%-204K-105.13%-4K
Net income attributable to the parent company 465.49%4.25M19.33%-889K-46.42%-962K38.51%-4.34M63.27%-1.24M46.43%-1.16M-50.55%-1.1M1.79%-657K0.00%-7.05M38.08%-3.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 465.49%4.25M19.33%-889K-46.42%-962K38.51%-4.34M63.27%-1.24M46.43%-1.16M-50.55%-1.1M1.79%-657K0.00%-7.05M38.08%-3.36M
Basic earnings per share 466.10%0.3719.33%-0.0773-46.42%-0.083738.51%-0.377163.27%-0.107446.43%-0.1011-50.55%-0.09581.81%-0.05710.00%-0.613338.08%-0.2924
Diluted earnings per share 159.37%0.0619.33%-0.0773-46.42%-0.083738.51%-0.377163.27%-0.107446.43%-0.1011-50.55%-0.09581.81%-0.05710.00%-0.613338.08%-0.2924
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday-1.11%